Search
19/08/2025
Established and Emerging Roles of Epigenetic Regulation in Diabetic Cardiomyopathy
Russell-Hallinan, A, Karuna, N, Lezoualc'h, F, Matullo, G, Baker, H, Bernard, M, Devaux, Y, Badimon, L, Vilahur, G, Rieusset, J, Derumeaux, GA, Watson, CJ. Established and Emerging Roles of Epigenetic Regulation in Diabetic Cardiomyopathy. DIABETES-METABOLISM RESEARCH AND REVIEWS. 2025; 41(6)DOI:10.1002/dmrr.70081. PMID:40831067. IF:6.000(Q1/2D).
20/01/2026
Revisiting tricuspid regurgitation: Historical insights and emerging research perspectives
Gonzalez-Cucharero, C, Vilahur, G, Saura, M, Hinojar, R, Zamorano, JL, Zaragoza, C. Revisiting tricuspid regurgitation: Historical insights and emerging research perspectives. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2026; 56(1)DOI:10.1111/eci.70138. PMID:41131691. IF:3.600(Q1/2D).
01/02/2025
Interplay between platelets and coagulation: from protective haemostasis to pathological arterial thrombosis
Vilahur, G, Fuster, V. Interplay between platelets and coagulation: from protective haemostasis to pathological arterial thrombosis. EUROPEAN HEART JOURNAL. 2025; 46(5)DOI:10.1093/eurheartj/ehae776. PMID:39673717. IF:35.600(Q1/1D).
18/09/2023
Lysyl oxidase-dependent extracellular matrix crosslinking modulates calcification in atherosclerosis and aortic valve disease.
Ballester-Servera C, Alonso J, Cañes L, Vázquez-Sufuentes P, Puertas-Umbert L, Fernández-Celis A, Taurón M, Rodríguez-Sinovas A, López-Andrés N, Rodríguez C, Martínez-González J. Lysyl oxidase-dependent extracellular matrix crosslinking modulates calcification in atherosclerosis and aortic valve disease.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2023; 167DOI:10.1016/j.biopha.2023.115469. PMID:37729730. IF:6.900(Q1/1D).
01/03/2026
Cognitive stagnation and executive function deficits in young children with SCN1A+ Dravet syndrome: Detailed characterization of onset, progression, and impact in the ENVISION natural history study
Sullivan, J, Perry, MS, Scheffer, IE, Wheless, J, Boronat, S, Brunklaus, A, Laux, L, Patel, AD, Roberts, C, Dlugos, D, Holder, D, Knupp, K, Lallas, M, Phillips, S, Segal, E, Lal, D, Wirrell, E, Zuberi, S, Gioia, G, Shaffer, R, Berl, MM, Wojnaroski, M, Christensen, S, King, A, James, ES, Vila, MC, Huang, N, Gofshteyn, JS, Rico, S. Cognitive stagnation and executive function deficits in young children with SCN1A+ Dravet syndrome: Detailed characterization of onset, progression, and impact in the ENVISION natural history study. EPILEPSIA. 2026; 67(3)DOI:10.1111/epi.70015. PMID:41251148. IF:6.600(Q1/1D).
01/04/2025
Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease.
Sivera Mascaró R, García Sobrino T, Horga Hernández A, Pelayo Negro AL, Alonso Jiménez A, Antelo Pose A, Calabria Gallego MD, Casasnovas C, Cemillán Fernández CA, Esteban Pérez J, Fenollar Cortés M, Frasquet Carrera M, Gallano Petit MP, Giménez Muñoz A, Gutiérrez Gutiérrez G, Gutiérrez Martínez A, Juntas Morales R, Ciano-Petersen NL, Martínez Ulloa PL, Mederer Hengstl S, Millet Sancho E, Navacerrada Barrero FJ, Navarrete Faubel FE, Pardo Fernández J, Pascual Pascual SI, Pérez Lucas J, Pino Mínguez J, Rabasa Pérez M, Sánchez González M, Sotoca J, Rodríguez Santiago B, Rojas García R, Turon-Sans J, Vicent Carsí V, Sevilla Mantecón T. Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease.. Neurologia. 2025; 40(3)DOI:10.1016/j.nrleng.2024.02.008. PMID:38431252. IF:(Q/D).
01/04/2026
Analytical and Clinical Validation of Action PharmaKitDx: A Comprehensive NGS Panel for the Identification of Pharmacogenetic Variants in Diverse Populations
Ramudo-Cela, L, Izquierdo-García, M, Dolores-Sequedo, M, Cubells-Perez, V, Bernal, S, Riera, P, Lasa, A, Torres-Juan, L, Asensio, VJ, Martínez-López, I, de Hevia, AO, Morín, M, Moreno-Pelayo, MA, Carmona-Antoñanzas, G, Pelayo, JP. Analytical and Clinical Validation of Action PharmaKitDx: A Comprehensive NGS Panel for the Identification of Pharmacogenetic Variants in Diverse Populations. Pharmaceuticals. 2026; 19(4)DOI:10.3390/ph19040568. PMID:42075824. IF:4.800(Q1/2D).
01/04/2026
Diagnostic yield of chromosomal microarray and virtual targeted gene panel analysis in adults with focal epilepsy: implications for sequential genetic testing strategy
Panadés-de Oliveira, L, Galeote, MS, Duran, EP, Vilella, L, Garcia, ACD, Principe, A, Metje, AP, Marti, IC, Pérez-Jurado, LA, Zucca, R, Boronat, S, Rocamora, R. Diagnostic yield of chromosomal microarray and virtual targeted gene panel analysis in adults with focal epilepsy: implications for sequential genetic testing strategy. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY. 2026; 137DOI:10.1016/j.seizure.2026.02.021. PMID:41785580. IF:2.800(Q2/5D).